South Korea delays plan for new single-stock options amid record volatility - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
商业快报

South Korea delays plan for new single-stock options amid record volatility

Concerns grow of frothiness in world’s best-performing equity market
00:00

{"text":[[{"start":8.6,"text":"South Korea’s main stock exchange has delayed the launch of weekly options tied to single stocks, in a sign of growing concern about frothiness in the world’s best-performing equity market this year."}],[{"start":20.35,"text":"The Korea Exchange had planned to launch contracts linked to four of the country’s largest companies — chipmakers Samsung Electronics and SK Hynix, carmaker Hyundai Motor and battery producer LG Energy Solution — on June 29."}],[{"start":34.5,"text":"But intense volatility in the market, including a single-day drop of 8 per cent this month followed by an 8 per cent rise the next day, spurred the bourse to push back the launch, it said on Thursday."}],[{"start":46.05,"text":"“Taking recent market conditions into consideration, we have decided to postpone the listing,” the Korea Exchange said in a statement to the FT."}],[{"start":54.199999999999996,"text":"The decision follows an admission of “regret” from the head of South Korea’s Financial Supervisory Service this week over the launch of leveraged exchange traded funds tied to Samsung and SK Hynix."}],[{"start":67.19999999999999,"text":"The financial products are popular among retail investors, who have piled into the market as the two chipmakers ride a historic AI boom. Samsung shares have more than doubled since the start of the year, while SK Hynix has more than quadrupled."}],[{"start":81.24999999999999,"text":"But the ETFs are also volatile, with some experiencing wrong-way moves because of liquidity issues. On June 8, the ACE SK Hynix Single Stock Leveraged ETF, which promises double the daily return of SK Hynix shares, surged nearly 50 per cent even as the underlying stock fell 7.7 per cent."}],[{"start":102.49999999999999,"text":"The Kospi benchmark has experienced wild swings this year, triggering an unprecedented number of trading curbs. The index plummeted 10 per cent on Tuesday but is up 9 per cent since then. A gauge measuring the Kospi’s volatility is at a record high of 95."}],[{"start":119.6,"text":"Half of South Korea’s adult population now has brokerage accounts, up from 21 per cent in 2019. Margin debt stands at a record Won37tn ($24bn)."}],[{"start":132.5,"text":"Regulators have justified the new weekly options as a way to broaden investment opportunities and reduce the incentive for South Koreans to trade similar derivatives on overseas exchanges."}],[{"start":143.35,"text":"The AI chip boom is driving astronomical returns on the Kospi, where Samsung and SK Hynix now comprise more than half of the index. Korea Exchange chief executive Jeong Eun-bo said last week that the high concentration of memory chip stocks could exacerbate volatility."}],[{"start":162.7,"text":"SK Hynix said in a regulatory filing on Wednesday it planned to list American depositary receipts on the Nasdaq exchange next month, giving US investors greater access to Asian chipmakers. Japanese memory chip supplier Kioxia said on Thursday it also planned to list in the US next year."}],[{"start":182.1,"text":"The Korea Exchange said it intended to proceed with weekly single-stock options “after taking into account market conditions and the state of institutional preparations”."}],[{"start":197.9,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1782365560_3587.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

FT社评:星链风波凸显欧洲亟须在太空领域迎头赶上

美国科技遥遥领先,但布鲁塞尔仍需建立自己的卫星网络并具备发射能力。

新加坡寻求追究相关公司责任,应对十年来最严重空气污染

政府威胁将对10家企业采取法律行动,称这些企业是邻国印尼山火的幕后推手,而山火造成的烟霾正在困扰新加坡。

美债收益率冲击下,欧洲必须自寻出路

埃里安:欧洲不能只盼着大西洋彼岸的借贷成本回落,它必须着手解决自身问题。

AI与通胀:央行行长该担忧到什么程度?

凯恩斯:这取决于一个价值万亿美元问题的答案:AI是否真能带来预期的生产力提升?

印度企业界的乐观情绪站得住脚吗?

印度企业界公开表达的乐观情绪,与家庭和投资者的焦虑情绪之间的落差日益明显。

Lex专栏:中国药企在药品开发领域获得一席之地

外国制药集团如今开始购买中国本土开发创新药物的授权。
设置字号×
最小
较小
默认
较大
最大
分享×